Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07762599
Silver Nanoparticle-Reinforced Double Antibiotic Paste in Symptomatic Apical Periodontitis: A Randomized Controlled TrialAll India Institute of Medical SciencesNot Yet RecruitingNot Applicable
NCT07762599Not Yet Recruiting
Not Applicable
Silver Nanoparticle-Reinforced Double Antibiotic Paste in Symptomatic Apical Per...All India Institute of Me...
NCT07764003
A Study of Efficacy and Safety of TLL-018 in CSU Participants With Inadequate Response to 2nd-generation H1-AHsHangzhou Highlightll Pharmaceutical Co., LtdNot Yet RecruitingPhase 2
NCT07764003Not Yet Recruiting
Phase 2
A Study of Efficacy and Safety of TLL-018 in CSU Participants With Inadequate Re...Hangzhou Highlightll Phar...
NCT07761936
Safinamide vs Placebo for Pain in Patients With Parkinson's Disease and Motor FluctuationsUniversita di VeronaRecruitingPhase 3
NCT07761936Recruiting
Phase 3
Safinamide vs Placebo for Pain in Patients With Parkinson's Disease and Motor Fl...Universita di Verona
NCT07762014
rBCG-N-RSV Vaccine in Adults Aged 60 Years and OlderBiothervax SpANot Yet RecruitingPhase 2
NCT07762014Not Yet Recruiting
Phase 2
rBCG-N-RSV Vaccine in Adults Aged 60 Years and OlderBiothervax SpA
NCT07762638
Post Trial Access to Lucerastat for Patients With Fabry Disease Who Participated in Study ID-069A302Idorsia Pharmaceuticals Ltd.Unknown
NCT07762638Unknown
—
Post Trial Access to Lucerastat for Patients With Fabry Disease Who Participated...Idorsia Pharmaceuticals L...
NCT07763977
The Effects and Neural Mechanisms of Vitamin D and Iron-Immune Homeostasis on Inhibitory Control in Obsessive-Compulsive DisorderGuangdong Provincial People's HospitalEnrolling By InvitationNot Applicable
NCT07763977Enrolling By Invitation
Not Applicable
The Effects and Neural Mechanisms of Vitamin D and Iron-Immune Homeostasis on In...Guangdong Provincial Peop...
NCT07764081
Progression, Management, and Clinical Outcomes of Coronary Artery AneurysmsNanjing First Hospital, Nanjing Medical UniversityRecruiting
NCT07764081Recruiting
—
Progression, Management, and Clinical Outcomes of Coronary Artery AneurysmsNanjing First Hospital, N...
NCT07763262
Autologous Nanofat Injection for Treatment of Stable VitiligoBenha UniversityCompletedNot Applicable
NCT07763262Completed
Not Applicable
Autologous Nanofat Injection for Treatment of Stable VitiligoBenha University
NCT07763028
Intrathecal Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells for Children With Cerebral PalsyGadjah Mada UniversityActive Not RecruitingPhase 1
NCT07763028Active Not Recruiting
Phase 1
Intrathecal Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells for Children...Gadjah Mada University
NCT07762209
Papilozumib Vaginal Gel for Exocervical Mucosal Restoration in Women With HPVAdknoma Health ResearchNot Yet RecruitingNot Applicable
NCT07762209Not Yet Recruiting
Not Applicable
Papilozumib Vaginal Gel for Exocervical Mucosal Restoration in Women With HPVAdknoma Health Research
NCT07762326
Effect of Artificial Intelligence Based Cognitive Training on Sleep Disorders and Quality of Life in Patients With Multiple SclerosisCairo UniversityNot Yet RecruitingNot Applicable
NCT07762326Not Yet Recruiting
Not Applicable
Effect of Artificial Intelligence Based Cognitive Training on Sleep Disorders an...Cairo University
NCT07764406
Effect Of Amniotomy In Early Labour On Duration Of LabourIndus Hospital and Health NetworkCompletedNot Applicable
NCT07764406Completed
Not Applicable
Effect Of Amniotomy In Early Labour On Duration Of LabourIndus Hospital and Health...
NCT07763496
Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical CancerARCAGY/ GINECO GROUPNot Yet RecruitingPhase 2
NCT07763496Not Yet Recruiting
Phase 2
Relacorilant and Nab-Paclitaxel in Recurrent or Metastatic Cervical CancerARCAGY/ GINECO GROUP
NCT07762950
Blood Biomarkers and Gut Microbiota for Pancreatic Cancer Risk in Chronic PancreatitisChanghai HospitalNot Yet Recruiting
NCT07762950Not Yet Recruiting
—
Blood Biomarkers and Gut Microbiota for Pancreatic Cancer Risk in Chronic Pancre...Changhai Hospital
NCT07762274
The RenAtt Method for Diagnosing and Treating Attention Problems After Stroke and Brain Injury, Further Validation of RehAtt® DiSTRO Assessment of Cognitive and Visual FunctionDepartment of clinical sciences at Danderyd hospitalCompleted
NCT07762274Completed
—
The RenAtt Method for Diagnosing and Treating Attention Problems After Stroke an...Department of clinical sc...
NCT07762079
A Study of Engagement in the "Résonance(s)" Musical and Experiential Immersion Program Among Patients With Mental Disorders - IRISFederation Regionale de Recherche en Psychiatrie et Sante Mentale OccitanieNot Yet RecruitingNot Applicable
NCT07762079Not Yet Recruiting
Not Applicable
A Study of Engagement in the "Résonance(s)" Musical and Experiential Immersion P...Federation Regionale de R...
NCT07763145
Effect of Citicoline on Neurological Severity Score and Cerebral Doppler Resistive Index in Neonatal Hypoxic Ischemic Encephalopathy: A Randomized Control TrialHayatabad Medical ComplexNot Yet RecruitingNot Applicable
NCT07763145Not Yet Recruiting
Not Applicable
Effect of Citicoline on Neurological Severity Score and Cerebral Doppler Resisti...Hayatabad Medical Complex
NCT07763119
Efficacy of Nebulised Inhalational Steroids in Neonates With Meconium Aspiration SyndromeKhyber Teaching HospitalCompletedPhase 3
NCT07763119Completed
Phase 3
Efficacy of Nebulised Inhalational Steroids in Neonates With Meconium Aspiration...Khyber Teaching Hospital
NCT07762066
Bridge to Belonging: Peer Led Intervention to Reduce Loneliness and Depression Among Older Gay and Bisexual MenFenway Community HealthRecruitingNot Applicable
NCT07762066Recruiting
Not Applicable
Bridge to Belonging: Peer Led Intervention to Reduce Loneliness and Depression A...Fenway Community Health
Result Breakdown
Not yet recruiting10 (50%)
Completed4 (20%)
Recruiting3 (15%)
Unknown1 (5%)
Enrolling by invitation1 (5%)
Active, not recruiting1 (5%)
not_applicable9 (45%)
Phase 24 (20%)
Not Specified4 (20%)
Phase 32 (10%)
Phase 11 (5%)